KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.71 Friday, 26th Apr 2024 CANF stock ended at $1.98. This is 3.13% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.71% from a day low at $1.91 to a day high of $2.00.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Aug 17, 2022 $0.85 $0.91 $0.85 $0.88 105 163
Aug 16, 2022 $0.87 $0.88 $0.86 $0.88 40 061
Aug 15, 2022 $0.87 $0.89 $0.86 $0.87 95 587
Aug 12, 2022 $0.90 $0.90 $0.86 $0.89 69 665
Aug 11, 2022 $0.88 $0.90 $0.86 $0.90 65 551
Aug 10, 2022 $0.86 $0.88 $0.83 $0.87 91 958
Aug 09, 2022 $0.88 $0.88 $0.84 $0.85 50 560
Aug 08, 2022 $0.87 $0.88 $0.83 $0.85 84 665
Aug 05, 2022 $0.84 $0.87 $0.84 $0.87 21 995
Aug 04, 2022 $0.86 $0.86 $0.84 $0.85 53 067
Aug 03, 2022 $0.86 $0.86 $0.84 $0.85 68 335
Aug 02, 2022 $0.85 $0.89 $0.83 $0.84 29 975
Aug 01, 2022 $0.85 $0.85 $0.83 $0.84 59 280
Jul 29, 2022 $0.82 $0.85 $0.81 $0.83 39 663
Jul 28, 2022 $0.84 $0.86 $0.80 $0.83 95 028
Jul 27, 2022 $0.83 $0.85 $0.82 $0.84 99 662
Jul 26, 2022 $0.83 $0.85 $0.81 $0.82 64 766
Jul 25, 2022 $0.85 $0.86 $0.84 $0.85 106 673
Jul 22, 2022 $0.87 $0.87 $0.82 $0.85 83 563
Jul 21, 2022 $0.84 $0.86 $0.82 $0.86 73 001
Jul 20, 2022 $0.82 $0.86 $0.82 $0.84 137 362
Jul 19, 2022 $0.83 $0.83 $0.80 $0.83 50 429
Jul 18, 2022 $0.81 $0.84 $0.80 $0.81 136 871
Jul 15, 2022 $0.84 $0.84 $0.781 $0.81 177 535
Jul 14, 2022 $0.86 $0.90 $0.80 $0.80 353 309
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT